Summary:
This study is being done to evaluate the efficacy and safety of an investigational oral drug in patients with relapsing multiple sclerosis (RMS).
Qualified Participants Must:
• Be male or female between 18 and 55 years of age
•
Have a diagnosis of multiple sclerosis
•
Not have a diagnosis of secondary or primary progressive multiple sclerosis
•
Not be pregnant or breastfeeding
Qualified Participants May Receive:
The study drug as well as all research-related tests, procedures and visits will be provided at no cost to the subject and their insurance.
Additionally, the subject will receive $50 for each scheduled clinic visit completed. The subject will not be charged for parking while attending study visits.